Mark P. Colonnese
2018 - Biota Pharmaceuticals
In 2018, Mark P. Colonnese earned a total compensation of $639.4K as Former Executive Vice President and Chief Financial Officer at Biota Pharmaceuticals, a 5% increase compared to previous year.
Compensation breakdown
| Salary | $43,725 |
|---|---|
| Other | $595,656 |
| Total | $639,381 |
Colonnese received $595.7K in other compensation, accounting for 93% of the total pay in 2018.
Colonnese also received $43.7K in salary.
Rankings
In 2018, Mark P. Colonnese's compensation ranked 11,049th out of 14,244 executives tracked by ExecPay. In other words, Colonnese earned more than 22.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,049 out of 14,244 | 22nd |
Division Manufacturing | 4,449 out of 5,758 | 23rd |
Major group Chemicals And Allied Products | 1,684 out of 2,119 | 21st |
Industry group Drugs | 1,428 out of 1,808 | 21st |
Industry Biological Products, Except Diagnostic Substances | 277 out of 339 | 18th |
Source: SEC filing on March 11, 2019.
Colonnese's colleagues
We found four more compensation records of executives who worked with Mark P. Colonnese at Biota Pharmaceuticals in 2018.